These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3741414)
1. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase. Tatsumi K; Kitamura S Biochem Biophys Res Commun; 1986 Jul; 138(1):312-7. PubMed ID: 3741414 [TBL] [Abstract][Full Text] [Related]
2. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Kitamura S; Sugihara K; Tatsumi K Biochem Mol Biol Int; 1994 Dec; 34(6):1197-203. PubMed ID: 7696992 [TBL] [Abstract][Full Text] [Related]
3. Loss of activity of an N1-methyl-4-pyridone-5-carboxamide-forming N1-methylnicotinamide oxidase in livers of rats fed 2-acetylaminofluorene. Ohkubo M; Fujimura S Cancer Res; 1978 Mar; 38(3):697-702. PubMed ID: 23895 [No Abstract] [Full Text] [Related]
4. A simple high-pressure liquid chromatographic assay for the N-hydroxy derivatives of phenacetin, acetaminophen, 2-acetylaminofluorene, and other hydroxamic acids. Hinson JA; Pohl LR; Gillette JR Anal Biochem; 1980 Jan; 101(2):462-7. PubMed ID: 7362041 [No Abstract] [Full Text] [Related]
5. Irreversible inhibition of the cytosolic metabolism of N-hydroxy-2-acetylaminofluorene by its glycolyl analog. Lim LO; Corbett BR; Corbett MD Cancer Lett; 1987 Oct; 37(2):205-11. PubMed ID: 3677055 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Wirth PJ; Alewood P; Calder I; Thorgeirsson SS Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016 [TBL] [Abstract][Full Text] [Related]
7. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene. Meerman JH; Tijdens RB Cancer Res; 1985 Mar; 45(3):1132-9. PubMed ID: 2578873 [TBL] [Abstract][Full Text] [Related]
8. Early effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on mitochondrial outer membrane enzyme activities of rat liver. Yoshida T; Yamamoto T; Matsuura Y; Kuroiwa Y Jpn J Pharmacol; 1985 Dec; 39(4):475-9. PubMed ID: 4094191 [TBL] [Abstract][Full Text] [Related]
9. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396 [TBL] [Abstract][Full Text] [Related]
10. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system. Staiano N; Erickson LC; Thorgeirsson SS Biochem Biophys Res Commun; 1980 Jun; 94(3):837-42. PubMed ID: 6994733 [No Abstract] [Full Text] [Related]
12. Effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on the cellular levels of epoxide hydratase, cytochrome P-450b, and NADPH-cytochrome c (P-450) oxidoreductase messenger ribonucleic acids. Gonzalez FJ; Samore M; McQuiddy P; Kasper CB J Biol Chem; 1982 Sep; 257(18):11032-6. PubMed ID: 6809765 [No Abstract] [Full Text] [Related]
13. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. Beranek DT; White GL; Heflich RH; Beland FA Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940 [TBL] [Abstract][Full Text] [Related]
14. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids. Wick MJ; Jantan IB; Hanna PE Biochem Pharmacol; 1988 Apr; 37(7):1225-31. PubMed ID: 3355596 [TBL] [Abstract][Full Text] [Related]
15. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster. Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863 [TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes. Smith TJ; Hanna PE Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis. Rosin MP; Stich HF Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207 [TBL] [Abstract][Full Text] [Related]
18. The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids. Kolanczyk RC; Rutks IR; Gutmann HR Chem Res Toxicol; 1991; 4(2):187-94. PubMed ID: 1782347 [TBL] [Abstract][Full Text] [Related]
19. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts. Lai CC; Miller EC; Miller JA; Liem A Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742 [TBL] [Abstract][Full Text] [Related]
20. The initiation of gamma-glutamyltranspeptidase positive foci in the rat liver by N-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol. Meerman JH Carcinogenesis; 1985 Jun; 6(6):893-7. PubMed ID: 2860981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]